Outcomes of Olverembatinib Based Regimen in Patients with Philadelphia Chromosome-Positive Advanced Leukemias: A Real-World, Single-Center ExperienceZiyu Wen, Na Xu, Zhiping Fan et al.|Blood|2022Cited by 3